Through community-based and tech-enabled care, we’ve created a replicable model that improves chronic disease outcomes and rebuilds trust in healthcare. The remaining barrier is leadership commitment.
Viatris’ broad portfolio of both off-patent and new, innovative medicines address many NCDs such as cardiovascular disease, diabetes, respiratory diseases, dermatology and ophthalmology.
We have taken a deliberate approach to expand access to our wide portfolio across geographies and income levels, where we seek to build and establish sustainable markets by nurturing innovation and competition.
Aflac, working with sports broadcaster, fashion entrepreneur and cancer survivor Erin Andrews, today launched Check for Cancer, a national movement aimed at boosting U.S. cancer screening rates by 10% over the next decade.
Aflac employee Cyronn Herrington had a unique childhood, starting at birth. He was diagnosed with hemophilia B, a chronic bleeding disorder that keeps blood from clotting properly.
The company opened a clinical physiology lab near the Five Points neighborhood of Denver, Colorado, to conduct its clinical trials not only with a wide array of participants but with more speed and frequency, leading to faster innovation.
In Colombia, the fight against disease outbreaks is reaching a critical point—and the collaboration between Direct Relief and FedEx is helping make a tangible difference.
If you’re taking a GLP-1 hormone medication like Ozempic, Wegovy, Victoza, or Mounjaro (or a compounded version), you already know its positive effects. Decreasing your appetite, calming cravings, reducing “food noise,” and helping you feel full.
In August 2023, Medtronic LABS and Virtua launched Healthy Neighbor. The goal was to improve health outcomes through a home healthcare program for patients living with high blood pressure and/or type 2 diabetes. And it’s working.
Jeff Simmons, President and CEO of Elanco Animal Health, recently joined the Bloomberg Businessweek Daily to discuss the company's strategic framework and detail why he sees sustainable value creation continuing for years to come.
PATH has launched a groundbreaking initiative to address the rising burden of hemoglobinopathies—particularly Thalassemia—in India, with the support of a grant from the Bristol Myers Squibb Foundation (BMS Foundation). The program aims to strengthen local health systems.
Join us as we travel the world to uncover real stories of impact—from landfills and energy transition to workplace safety, emerging contaminants, and...
As sustainability leaders, we implement our sustainability strategy across all company activities along the entire value chain, from raw materials to...
Cascale shares insights regarding policy and regulation impacting the consumer goods industry, and highlights how it's supporting members prepare for...
